Dr. Amy Abernethy is known for modernizing the FDA’s approach to big data. Now as President of Product Development and Chief Medical Officer of Alphabet’s Verily, and a member of Sixth Street’s Scientific Advisory Board, she’s exploring approaches to real-world data and developing tools to bring advanced therapeutics to patients. Amy joins our host, David Stiepleman, as well as Sixth Street’s Vice Chairman, Marty Chavez, as we discuss her contributions to transforming FDA processes and how today’s scientific advancements can lead toward improved public health outcomes.

---

Hosted on Acast. See acast.com/privacy for more information.